BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35040075)

  • 41. Does Advanced Imaging Have a Role in Detecting Local Recurrence of Soft-tissue Sarcoma?
    England P; Hong Z; Rhea L; Hirbe A; McDonald D; Cipriano C
    Clin Orthop Relat Res; 2020 Dec; 478(12):2812-2820. PubMed ID: 32667755
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Community compliance with carcinoembryonic antigen: follow-up of patients with colorectal cancer.
    Spratlin JL; Hui D; Hanson J; Butts C; Au HJ
    Clin Colorectal Cancer; 2008 Mar; 7(2):118-25. PubMed ID: 18501071
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Concordance with ASCO guidelines for surveillance after colorectal cancer treatment: a population-based analysis.
    Sisler JJ; Seo B; Katz A; Shu E; Chateau D; Czaykowski P; Wirtzfeld D; Singh H; Turner D; Martens P
    J Oncol Pract; 2012 Jul; 8(4):e69-79. PubMed ID: 23181004
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The robust performance of carcinoembryonic antigen levels after adjuvant chemotherapy for the recurrence risk stratification in patients with colorectal cancer.
    Ozawa T; Matsuda K; Ishihara S; Fukushima Y; Shimada R; Hayama T; Nozawa K; Hashiguchi Y
    J Surg Oncol; 2021 Jul; 124(1):97-105. PubMed ID: 33848373
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Is there a role for (99m)Tc-anti-CEA monoclonal antibody imaging in the diagnosis of recurrent colorectal carcinoma?
    Fuster D; Maurel J; Muxí A; Setoain X; Ayuso C; Martín F; Ortega ML; Fuertes S; Pons F
    Q J Nucl Med; 2003 Jun; 47(2):109-15. PubMed ID: 12865871
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Imaging with indium111-labeled anticarcinoembryonic antigen monoclonal antibody ZCE-025 of recurrent colorectal or carcinoembryonic antigen-producing cancer in patients with rising serum carcinoembryonic antigen levels and occult metastases.
    Patt YZ; Lamki LM; Shanken J; Jessup JM; Charnsangavej C; Ajani JA; Levin B; Merchant B; Halverson C; Murray JL
    J Clin Oncol; 1990 Jul; 8(7):1246-54. PubMed ID: 2193120
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Physician follow-up and observation of guidelines in the post treatment surveillance of colorectal cancer.
    Vargas GM; Sheffield KM; Parmar AD; Han Y; Brown KM; Riall TS
    Surgery; 2013 Aug; 154(2):244-55. PubMed ID: 23889952
    [TBL] [Abstract][Full Text] [Related]  

  • 48. DIAGNOSTIC ROLE OF FLUORINE-18 (18F) FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY COMPUTED TOMOGRAPHY IN DETECTING RECURRENT DISEASE IN PATIENTS WITH COLORECTAL CANCER AND ELEVATED CARCINOEMBRYONIC ANTIGEN.
    Matovina E; Mihailović J; Nikoletić K; Srbovan D
    Med Pregl; 2015; 68(11-12):376-81. PubMed ID: 26939303
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Yield of routine imaging after curative colorectal cancer treatment.
    Jochmans I; Topal B; D'Hoore A; Aerts R; Vanbeckevoort D; Bielen D; Haustermans K; Van Cutsem E; Penninckx F
    Acta Chir Belg; 2008; 108(1):88-92. PubMed ID: 18411580
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detection efficiency of colorectal carcinoma recurrence using technetium pertechnetate-anti-carcinoembryonic antigen monoclonal antibody BW 431/26.
    Zwas ST; Goshen E; Rath P; Brenner H; Klein E; Ben-Ari G
    Cancer; 1995 Jul; 76(2):215-22. PubMed ID: 8625094
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Value of postoperative surveillance after radical surgery for colorectal cancer: results of a cohort study.
    Castells A; Bessa X; Daniels M; Ascaso C; Lacy AM; García-Valdecasas JC; Gargallo L; Novell F; Astudillo E; Filella X; Piqué JM
    Dis Colon Rectum; 1998 Jun; 41(6):714-23; discussion 723-4. PubMed ID: 9645739
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 18F-FDG PET-CT in evaluation of postoperative colorectal cancer patients with rising CEA level.
    Mittal BR; Senthil R; Kashyap R; Bhattacharya A; Singh B; Kapoor R; Gupta R
    Nucl Med Commun; 2011 Sep; 32(9):789-93. PubMed ID: 21760561
    [TBL] [Abstract][Full Text] [Related]  

  • 53. (18)F-DG PET/CT in detection of recurrence and metastasis of colorectal cancer.
    Chen LB; Tong JL; Song HZ; Zhu H; Wang YC
    World J Gastroenterol; 2007 Oct; 13(37):5025-9. PubMed ID: 17854148
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detecting Asymptomatic Recurrence in Early-Stage Endometrial Cancer: The Value of Vaginal Cytology, Imaging Studies, and CA-125.
    Lee JY; Kim JH; Seo JW; Kim HS; Kim JW; Park NH; Song YS
    Int J Gynecol Cancer; 2016 Oct; 26(8):1434-9. PubMed ID: 27465903
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Radioimmunoguided surgery in recurrent colorectal cancer: the role of carcinoembryonic antigen, computerized tomography, and physical examination.
    Sardi A; Agnone CM; Nieroda CA; Mojzisik C; Hinkle G; Ferrara P; Farrar WB; Bolton J; Thurston MO; Martin EW
    South Med J; 1989 Oct; 82(10):1235-44. PubMed ID: 2799440
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The diagnostic accuracy of a single CEA blood test in detecting colorectal cancer recurrence: Results from the FACS trial.
    Shinkins B; Nicholson BD; Primrose J; Perera R; James T; Pugh S; Mant D
    PLoS One; 2017; 12(3):e0171810. PubMed ID: 28282381
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ability of 18F-FDG PET/CT to diagnose recurrent colorectal cancer in patients with elevated CEA concentrations.
    Kyoto Y; Momose M; Kondo C; Itabashi M; Kameoka S; Kusakabe K
    Ann Nucl Med; 2010 Jun; 24(5):395-401. PubMed ID: 20364373
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection of recurrences during follow-up after liver surgery for colorectal metastases: both carcinoembryonic antigen (CEA) and imaging are important.
    Verberne CJ; Wiggers T; Vermeulen KM; de Jong KP
    Ann Surg Oncol; 2013 Feb; 20(2):457-63. PubMed ID: 22948771
    [TBL] [Abstract][Full Text] [Related]  

  • 59. No benefit of more intense follow-up after surgery for colorectal cancer in the risk group with elevated CEA levels - An analysis within the COLOFOL randomized clinical trial.
    Egenvall M; Martling A; Veres K; Horváth-Puhó E; Wille-Jørgensen P; Høirup Petersen S; Laurberg S; Sørensen HT; Syk I;
    Eur J Surg Oncol; 2021 Aug; 47(8):2053-2059. PubMed ID: 33846037
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Surveillance strategies in the follow-up of melanoma patients: too much or not enough?
    Kurtz J; Beasley GM; Agnese D; Kendra K; Olencki TE; Terando A; Howard JH
    J Surg Res; 2017 Jun; 214():32-37. PubMed ID: 28624057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.